share_log

太龙药业(600222.SH):公司及子公司通过高新技术企业重新认定

Tailong Pharmaceutical (600222.SH): The company and subsidiaries have passed the re-certification of high-tech enterprises

Gelonghui Finance ·  Dec 19, 2023 04:11

Gelonghui (600222.SH) announced on December 19|Tailong Pharmaceutical () announced that according to the “Notice on the Filing of the First Batch of High-tech Enterprises” issued by the National High-tech Enterprise Accreditation Management Leading Group Office, it was learned that the company and its holding subsidiary, Beijing New Leading Pharmaceutical Technology Development Co., Ltd., a wholly-owned subsidiary of Beijing New Leading Pharmaceutical Technology Development Co., Ltd., have successfully passed the high-tech enterprise certification. This is a re-certification carried out by the company and the Zhengzhou Deep Blue Haiyuan High-tech Enterprise Certificate after its validity period expires.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment